Giant cell tumor of the bone
Also known as: Giant Cell Tumors of Bone / Giant Cell Tumor of Bone / Bone giant cell tumour / Bone Giant Cell Tumor / Osteoclastoma / Bone giant cell tumour benign / Benign bone giant cell tumor / Benign bone giant cell tumour / Bone giant cell tumor benign / Giant cell tumor of bone (morphologic abnormality) / Giant cell tumor of bone (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB06643 | Denosumab | A RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06643 | Denosumab | Tumor necrosis factor ligand superfamily member 11 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00399 | Zoledronic acid | 1 / 2 | Terminated | 1 |
DB00041 | Aldesleukin | 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
DB01254 | Dasatinib | 2 | Completed | 1 |
DB06643 | Denosumab | 2 | Completed | 2 |
DB06643 | Denosumab | 2 | Terminated | 1 |
DB01073 | Fludarabine | 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB17107 | Lifileucel | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB00399 | Zoledronic acid | 2 | Terminated | 1 |
DB06643 | Denosumab | 3 | Not Yet Recruiting | 1 |
DB06643 | Denosumab | 3 | Unknown Status | 1 |
DB00399 | Zoledronic acid | 3 | Recruiting | 1 |
DB06643 | Denosumab | 4 | Completed | 1 |
DB06643 | Denosumab | 4 | Recruiting | 1 |
DB06643 | Denosumab | Not Available | Completed | 1 |
DB06643 | Denosumab | Not Available | Unknown Status | 1 |